October 13, 2022
Pfizer and BioNTech on October 13 filed their COVID-19 vaccine adapted to the BA.4/5 strains of the Omicron variant for use in children aged five through 11 in Japan. The bivalent vaccine contains mRNA encoding the spike-protein of both original...read more